Inovio Biomedical Corp (NASDAQ:INO)

CAPS Rating: 2 out of 5

A biomedical company which deals in developing human applications of electroporation, which uses brief, controlled electrical pulses to increase cellular uptake of a useful biopharmaceuticals.

Results 1 - 20 of 42 : 1 2 3 Next »

Recs

0
Member Avatar pchop12316 (59.39) Submitted: 3/19/2015 3:53:42 PM : Outperform Start Price: $9.45 INO Score: -11.61

who tossed out this nice baby with the bathwater

Recs

0
Member Avatar zzlangerhans (99.83) Submitted: 2/25/2015 2:06:22 AM : Outperform Start Price: $7.05 INO Score: +18.51

Inovio's chart is looking rather sickly this year but I don't see why the stock has fallen so far out of favor. I'm not a fan of companies that kick up clouds of dust for years without much to show for it, but Inovio finally produced some hard data for VGX-3100 last July and they're in the midst of planning a phase III trial to begin in early 2016. The rest of the pipeline is all phase I, phase I/II stuff like they've been churning since forever but with the market cap headed below 400M Inovio isn't looking as ridiculously overvalued as it was last year.

Recs

0
Member Avatar Allstar13913 (99.82) Submitted: 9/12/2014 10:58:34 PM : Underperform Start Price: $10.40 INO Score: +25.18

Uses known stock promoter Redchip.com, for a pump and dump scheme. Garbage.

Recs

0
Member Avatar Ronbo69 (< 20) Submitted: 7/22/2014 10:13:49 PM : Outperform Start Price: $13.87 INO Score: -44.61

How about a company with enough money to continue R&D work without any help from the big Pharma, Things are looking good going into results from Ph. II clinical, and with many other ongoing projects, eg. prostate research, things are very exciting.

Recs

0
Member Avatar kurdlingsvoice (< 20) Submitted: 6/12/2014 3:11:36 PM : Outperform Start Price: $8.79 INO Score: -13.27

Catalysts!

Recs

0
Member Avatar egnarops (24.02) Submitted: 6/11/2014 5:06:55 PM : Outperform Start Price: $8.82 INO Score: -12.91

Inovio is on the cusp of radically changing how we approach the treatment of cancer, malaria , all strains of flu, mers and many other deadly diseases .

Recs

0
Member Avatar Jared1048 (< 20) Submitted: 3/20/2014 3:50:38 PM : Outperform Start Price: $15.10 INO Score: -55.41

The product line up that they are going to come out with are second to none! Look into this company and you will soon see its extremely undervalued! checkout there expected earnings in 2017

Recs

1
Member Avatar ColossalSlug (< 20) Submitted: 3/13/2014 3:42:44 PM : Outperform Start Price: $13.64 INO Score: -50.98

Inovio has roughly a dozen vaccines in current trial that are very promising as indicated in previous studies. In addition to the keen abilities in R&D by some of the best researchers in the business, their partnerships are solid and will be extremely beneficial in the development and FDA application areas. The scope, success, and magnitude of what this company has in the pipeline - some with phase 2 trial results in 2014 - is just too hard to dismiss. Yes, investments in INO will be volatile and data driven, but we should be seeing fairly consistent stair-stepping to the upside for years to come.

Recs

0
Member Avatar SetMyPeopleFree (30.66) Submitted: 3/7/2014 12:08:32 PM : Outperform Start Price: $13.96 INO Score: -50.75

I bought a few hundred shares under $3, and added enough over 3 up to 3.55 to average $3. My biggest failure is not getting much more at $2.38 a couple weeks ago, or any at all on intra-day quick drop to $3 even last week. The science is mankind changing, and the CEO is not only genius in his field, but a Wharton MBA. This is a 10 bagger by next year, and perhaps a possible 500x even here near 3.50.

Recs

0
Member Avatar pjlullo (< 20) Submitted: 2/24/2014 11:04:40 AM : Outperform Start Price: $14.16 INO Score: -53.03

Pharms are going to be hot this year

Recs

0
Member Avatar samuelbeh (< 20) Submitted: 2/20/2014 9:33:24 AM : Outperform Start Price: $11.44 INO Score: -40.55

Expecting positive results from clinical trials.

Recs

0
Member Avatar TerryHoodSr (79.90) Submitted: 2/19/2014 9:23:22 AM : Outperform Start Price: $8.60 INO Score: -17.89

upside potential, TP $4

Recs

0
Member Avatar JungleDoctor (< 20) Submitted: 2/12/2014 11:59:15 PM : Outperform Start Price: $10.48 INO Score: -35.17

If malaria vaccine succeeds, will be a world changer

Recs

0
Member Avatar SqwiiTrader (< 20) Submitted: 1/21/2014 3:24:16 AM : Outperform Start Price: $10.04 INO Score: -29.86

Flu play

Recs

0
Member Avatar jdowning22 (< 20) Submitted: 1/18/2014 8:06:56 PM : Outperform Start Price: $10.04 INO Score: -30.78

New drugs in the pipeline for quite awhile.

Recs

0
Member Avatar slammasters98 (< 20) Submitted: 11/23/2013 7:35:31 PM : Outperform Start Price: $8.68 INO Score: -19.30

Important phase studies ending or ended and with crucial data coming out in the next 8 months that can blow up this stock like it did in Sept. when it ran to 3.00. New positive data will drive additional partnership talks, more funding, and more institutional buying

Recs

0
Member Avatar Brooer (< 20) Submitted: 11/17/2013 9:18:56 PM : Outperform Start Price: $7.96 INO Score: -11.27

Inovio recently made a deal with Roche Holdings AG for exclusive rights to just two of its many products still in early investigative stages.This deal could eventually be worth hundreds of millions and is only the first of what will hpoefully be many deals with big pharma in the near future.

Recs

0
Member Avatar remrem44 (45.46) Submitted: 8/5/2013 1:28:54 PM : Outperform Start Price: $5.00 INO Score: +42.16

5 in less 6 months

Recs

0
Member Avatar SAnitaB (< 20) Submitted: 8/2/2013 3:12:18 PM : Outperform Start Price: $8.14 INO Score: -19.99

Great trials results on several projects recently

Recs

0
Member Avatar stardog900 (< 20) Submitted: 7/27/2013 2:08:23 PM : Outperform Start Price: $6.00 INO Score: +14.39

If trials are successful, as is anticipated, this stock should outperform the S&P 500 over the next year or two.

Results 1 - 20 of 42 : 1 2 3 Next »

Featured Broker Partners


Advertisement